• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻风病患者乙酰化酶表型对氨苯砜耐药麻风病出现的影响。

Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.

作者信息

Raj P P, Aschhoff M, Lilly L, Balakrishnan S

机构信息

St. Thomas Hospital and Leprosy Centre, Chettupattu, Tamil Nadu.

出版信息

Indian J Lepr. 1988 Jul;60(3):400-6.

PMID:3058828
Abstract

The half time of disappearance of dapsone and monoacetyl dapsone and the acetylator phenotype of the leprosy patients who harboured dapsone sensitive and dapsone resistant M. leprae was assessed in 27 subjects. Sixteen patients were rapid acetylators, five were slow and six were intermediate acetylators. The mean T 1 1/2 lives of dapsone (30.26 +/- 11.0) and monoacetyl dapsone (31.11 +/- 12.0) were also studied in the above patients. The percentage of different acetylators in both resistant and sensitive groups were similar showing no correlation between the emergence of drug resistance and the phenotype of the patient. The mean time of disappearance of DDS and MAD in the different acetylators did not show significant difference. The ratios of MAD/DDS in an individual at 3, 6 or 24 hours after the dose were similar. The mean T 1 1/2 lives of DDS and MAD in resistant and sensitive patients also showed no difference. Neither T 1 1/2 lives of DDS or MAD nor the acetylator phenotype seem to influence the emergence of dapsone resistance.

摘要

在27名受试者中评估了氨苯砜和单乙酰氨苯砜的消除半衰期以及携带对氨苯砜敏感和耐药麻风杆菌的麻风病患者的乙酰化表型。16名患者为快速乙酰化者,5名是慢速乙酰化者,6名是中间型乙酰化者。还对上述患者的氨苯砜(30.26 +/- 11.0)和单乙酰氨苯砜(31.11 +/- 12.0)的平均半衰期进行了研究。耐药组和敏感组中不同乙酰化者的百分比相似,表明耐药性的出现与患者的表型之间没有相关性。不同乙酰化者中氨苯砜和单乙酰氨苯砜的平均消失时间没有显著差异。给药后3、6或24小时个体中氨苯砜单乙酰氨苯砜的比值相似。耐药和敏感患者中氨苯砜和单乙酰氨苯砜的平均半衰期也没有差异。氨苯砜或单乙酰氨苯砜的半衰期以及乙酰化表型似乎都不会影响氨苯砜耐药性的出现。

相似文献

1
Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.麻风病患者乙酰化酶表型对氨苯砜耐药麻风病出现的影响。
Indian J Lepr. 1988 Jul;60(3):400-6.
2
Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
Lepr India. 1977 Jan;49(1):59-64.
3
Acetylation of dapsone by human whole blood.氨苯砜在人全血中的乙酰化作用。
Int J Clin Pharmacol Ther Toxicol. 1993 Jan;31(1):18-22.
4
Drug sensitivity of M. leprae isolated from leprosy patients administered DDS for long period of time.从长期接受氨苯砜治疗的麻风病人中分离出的麻风杆菌的药物敏感性。
Acta Leprol. 1978 Oct-Dec(73):13-28.
5
[Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].[麻风分枝杆菌对氨苯砜和利福平的耐药性:关于在佛得角地区(塞内加尔)开展的一项调查]
Med Trop (Mars). 1987 Apr-Jun;47(2):171-5.
6
Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.关于麻风病现场病例和住院病例中对砜类耐药麻风杆菌菌株的研究。
Lepr India. 1983 Jan;55(1):71-5.
7
Dapsone resistance in Mycobacterium leprae.麻风分枝杆菌中的氨苯砜耐药性。
Lepr Rev. 2000 Dec;71 Suppl:S91-5.
8
DDS-resistant leprosy.耐二氮杂苯麻风病。
Int J Lepr Other Mycobact Dis. 1985 Mar;53(1):115-8.
9
The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.氨苯砜及乙酰化氨苯砜在血清和唾液中的药代动力学。
Int J Clin Pharmacol Biopharm. 1979 Apr;17(4):159-63.
10
Acetylator phenotype in Iraqi patients with atopic dermatitis.伊拉克特应性皮炎患者的乙酰化酶表型
Dermatol Online J. 2006 Dec 10;12(7):1.

引用本文的文献

1
Development of a multivariate predictive model for dapsone adverse drug events in people with leprosy under standard WHO multidrug therapy.在世卫组织标准多药疗法下,针对麻风病患者氨苯砜药物不良事件建立多变量预测模型。
PLoS Negl Trop Dis. 2024 Jan 25;18(1):e0011901. doi: 10.1371/journal.pntd.0011901. eCollection 2024 Jan.